Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 40

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 40
---
 that are exercisable within 60 days following April 7, 2025, 9,798 shares held directly by Mr. Cola, and 19,500 shares of common stock issuable to Mr. Cola upon the vesting of restricted stock units that have vested or are scheduled to vest within 60 days following April 7, 2025.

Includes 9,887 shares of common stock acquired through our Employee Stock Purchase Plan, 3,840 shares of common stock held in the Phathom Stock Fund in our 401(k) plan, 1,601,884 shares of common stock issuable to Ms. Curran upon the exercise of options that are exercisable within 60 days following April 7, 2025, and 395,750 shares of common

<div align='center'>26</div>

stock issuable to Ms. Curran upon the vesting of restricted stock units that have vested or scheduled to vest within 60 days following April 7, 2025. Fractional shares rounded to nearest whole share.

Includes 8,306 shares of common stock acquired through our Employee Stock Purchase Plan, 1,911 shares of common stock held in the Phathom Stock Fund in our 401(k) plan, and 151,249 shares of common stock issuable to Ms. Henderson upon the exercise of options that are exercisable within 60 days following April 7, 2025. Fractional shares rounded to nearest whole share.

Consists of 37,500 shares held directly by Mr. Karbe, 62,500 shares of common stock issuable to Mr. Karbe upon the exercise of options that are exercisable within 60 days following April 7, 2025, and 19,500 shares of common stock issuable to Mr. Karbe upon the vesting of restricted stock units that have vested or are scheduled to vest within 60 days following April 7, 2025.

Consists of 113,360 shares of common stock issuable to Ms. Kunz upon the exercise of options that are exercisable within 60 days following April 7, 2025, and 19,500 shares of common stock issuable to Ms. Kunz upon the vesting of restricted stock units that have vested or are scheduled to vest within 60 days following April 7, 2025.

Includes 9,295 shares of common stock acquired through our Employee Stock Purchase Plan, 3,579 shares of common stock held